Navigation Menu is only visible when JavaScript is enabled
American Society of Human Genetics - San Diego - October 18-22, 2014 Contact Search
 

Abstracts

 
  Rules and Guidelines
  Topic Categories
  Keywords
  Submission Instructions
  Confirmations/Receipt
  Revisions/Changes
  First Author Name Changes
  Withdrawals
  Acceptance and Programming
  Publication
  Licensing Agreement
  How to Cite Abstracts
  Abstract FAQ's
   
   
   




Abstracts

Questions: ashgmeetings@ashg.org

 

 

Note: Authors who submit abstracts are not automatically registred for the meeting.




abstract search



Abstract Acceptance and Programming

 

Abstract Assignments (Platform, Poster, and Plenary)

The letters below provide access to alphabetical lists of the authors whose abstracts were accepted for the 64th ASHG Annual Meeting. To view abstract program assignments, click on the first letter of the first (presenting) author's
last name (surname). Co-author names are not listed:
 

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

 

Instructions for Poster Presentations

Speaker Guidelines (Invited/Plenary/Platform)

Preparing Effective PowerPoint Presentations

 

 

How does my abstract get programmed? After the deadline of June 4, the 2014 Program Committee completes the following steps to program abstracts for the Annual Meeting:

 

Step 1. The Shuffle Phase: The Program Committee reviews abstracts to ensure that they have been submitted to the correct topic category. If not, the abstract is moved to a more appropriate topic where it can be reviewed by experts in the field.

 

Step 2. The Review and Scoring Phase: Each abstract is reviewed by three reviewers. Each reviewer scores the abstracts independently and without knowledge of the score given by the other reviewers. Abstract scores range from 1 (highest) to 8 (lowest). The best cumulative score that an abstract can obtain from three reviewers is 3 (1+1+1). The average score is approximately 12, and only a small number of abstracts are rejected. Abstract scores are confidential and are not released to authors.

 

Step 3. The Assignment Phase: The Program Committee assigns abstracts to either platform sessions, poster sessions, or plenary sessions. The top-scoring abstracts from each topic category are considered for inclusion in the plenary session (usually four to six talks). Selections are based on the cumulative score as well as the impact of the science and the balance of topics across the session. Only eight percent of the 3,000+ abstracts received are selected for platform sessions; the remainder of the accepted abstracts are assigned to posters. Each topic receives a percentage of platform talks in rough proportion to the number of submitted abstracts in that topic category. Multi-disciplinary cross topics are created when there are not enough abstracts in one topic to create a full session. In 2014, there will be a total of 400 platform presentations (five platform symposia time slots, with 10 concurrent sessions each and eight presentations per session).

 

Once a presentation has been programmed, a first author who is unable to make the presentation in person is asked to notify the ASHG office immediately at ashgmeetings@ashg.org so that a notation can be included in the program addendum.

 

Reasons why abstracts are rejected: While it is rare for an abstract to be rejected, the ASHG Program Committee reserves the right, at its sole discretion, to reject any abstract deemed inappropriate. To increase the likelihood that your abstract will be accepted, please review the following:

 

Make sure your abstract includes results. Whether new findings presented in an abstract are experimental or theoretical, specific results MUST be included. The results, whether experimental or calculated, must be stated in the abstract. An author is free to include his or her latest data in the final presentation at the meeting, but the results included in the original abstract must be substantive.

 

Avoid promotion of a commercial product or service. The Program Committee tries to ensure ASHG presentations are not used as venues for commercial promotion. The ASHG will NOT accept abstracts that promote specific products without providing new scientific insights or data. Statements like, “We show that X product works better than Y product” are clear indicators of promotion and will be cause for rejection. In contrast, an abstract that presents findings of interest to human geneticists, but mentions that the work was done with a proprietary and copyrighted product, in which co-authors include those at the company who made the product, may be deemed acceptable.

 

Avoid prior publication: Results or studies that have been published or that will be accepted for publication elsewhere prior to the submission deadline of June 4, 2014, as well as studies that will be published prior to October 2014 may be rejected or scored accordingly. This includes abstracts that have been accepted for presentation at another conference. Abstracts that contain new data will still be considered by the Program Committee.

 

Please refer to the rules and guidelines section for additional information.

 


 

Abstract Submission

There is no fee to submit an abstract. All abstracts must be submitted by Wednesday, June 4, 2014 at 8:00 pm (U.S. East Coast time). All submitting authors will be asked to confirm the following statements: (1) I have read, understand, and agree to the rules and guidelines; (2) I am submitting this abstract with the intent of attending the ASHG Annual Meeting and presenting; and (3) I confirm that each co-author has been informed of this abstract submission and has agreed to all information as it was submitted. note: Authors who submit abstracts are not automatically registered for the meeting. In order to participate in the meeting and make your presentation, authors must register for the meeting, and cover the costs of hotel and travel.

 


 

Abstract Confirmation/Receipt

After you submit your abstract, you will receive an immediate on-screen confirmation of receipt. You will not receive a separate confirmation email. Please print this information and keep it for your records. You will need this information when returning to the submission site. If you do not receive an on-screen confirmation of receipt, then your abstract was not successfully submitted and it will not be reviewed or programmed by the 2014 Program Committee.

 


 

Abstract Revisions/Changes

To make any changes to an abstract (including author changes), return to the abstract submission site and select “revise my abstract.” You will need your abstract control number, personal ID number, and the last name of the first author listed on the abstract. You are not permitted to change the first author’s name at the revision site (see instructions below). note: Revisions will not be permitted from June 1 through June 4, when the submission site is extremely busy.

 


 

Abstract First Author Name Change

First authors cannot be changed under the revisions link. If it is critical that you change the name of the first author, you must first withdraw the abstract and then submit a new abstract with the new name.

 


 

Abstract Withdrawals

To withdraw an abstract, return to the submission site and select “withdraw my abstract.” You will need your abstract control number, personal ID number, and first author’s last name. Withdrawal requests must be made by June 6, 2014, 5:00 pm U.S. Eastern Time. All accepted abstracts will be published in the ASHG 2014 Meeting Program and cannot be withdrawn from publication after June 6 (even at the request of the author and/or principal investigator). Abstracts not withdrawn by June 6 will be reviewed and programmed by members of the Program Committee.

 


 

Abstract Letters of Invitation (for Visa purposes)

Letters of Invitation will be provided only to individuals who have submitted an abstract or registered for the ASHG Annual Meeting. You will be given a link within your confirmation of your abstract and/or registration to generate your letter of invitation. You will need this letter when applying for a visa. All attendees are urged to apply for a visa as soon as possible. Waiting until you receive your abstract confirmation (which is not available until August) will delay your visa process and may result in your visa being denied. Click here to view information on visas and access into the U.S. for attendees traveling from other countries.

 


 

Abstract Publication

Abstracts selected for presentation will be available on the 2014 meeting website in late August and are published online. At this time, your abstract and all information will become a matter of public record and may be referenced by ASHG, media relations staff, and others. Please review the abstract licensing agreement/copyright policy under the abstract rules and guidelines for more information. The 2014 meeting website will include a searchable program and an individualized meeting itinerary planner after the abstracts have been posted online. Abstract search and printing stations will also be available on site in the registration area at the San Diego Convention Center, Lobby D.

 


 

Abstract Licensing Agreement

In consideration of acceptance of the abstract by the American Society of Human Genetics (ASHG), the submitting author grants ASHG a nonexclusive, perpetual, worldwide license to copy, reproduce, and publish the abstract in ASHG's online or print publication of ASHG abstracts and/or other compilations or collective works to be assembled and owned by ASHG (together, "Collective Works") in any form or medium now existing or hereafter created throughout the world. The submitting author understands and agrees that ASHG shall own all rights, including copyright, in and to the Collective Works including the right to: 

 

  1. Distribute, reproduce, license, display, perform, lend, lease, or transfer rights to the Collective Works to third parties,

  2. Prepare derivative works of the Collective Works, and

  3. Register the Collective Works in ASHG's own name with the U.S. Copyright Office. 

 

It is understood that the submitting author and/or third parties with copyrights shall retain copyright in and to the abstract contributed by the submitting author to a Collective Work. The submitting author affirms that he/she is the author and owner of the abstract and holds all copyrights in and to the abstract, or has secured any third party permissions necessary to grant ASHG the above rights. The submitting author is responsible for providing any related third party with a copy of this grant of rights.

 


 

Abstract Licensing Agreement: (for all US government employees and government trainees)

In consideration of acceptance of the abstract by the American Society of Human Genetics (ASHG), the submitting author grants ASHG a nonexclusive, perpetual, worldwide, and unrestricted right to copy, reproduce, and publish the abstract in ASHG's online or print publication of ASHG abstracts and/or other compilations or collective works to be assembled and owned by ASHG (together, "Collective Works") in any form or medium now existing or hereafter created throughout the world.

The submitting author affirms that he/she is the author and owner of the abstract and that he/she has secured any needed third party copyright permissions. ASHG understands that the submitting author prepared and wrote the abstract as part of her/his official duties as a U.S. government employee and all abstracts, presentation(s), recording(s), and related material(s) will be an official work of the United States Government. Therefore, copyright may not be established in the United States (17 U.S.C. § 105).

 


 

How to Cite Abstracts

The following is a suggested style for citing ASHG 2014 Meeting abstracts:

 

Example Only

Simpson R.S., Barnes P., Disruption of the microRNA pathway; (Abstract/Program #XX). Presented at the 64th Annual Meeting of The American Society of Human Genetics, Date, Location (e.g., October 20, 2014 in San Diego, CA).

Abstracts from previous ASHG Annual Meetings are available through the Past ASHG Meetings Archive. In your abstract citation, use the appropriate URL for the meeting in which the abstract was presented.

 

 

Contact Meeting Management

 

The American Society of Human Genetics, Incorporated | 9650 Rockville Pike, Bethesda, Maryland 20814
society@ashg.org 1-866-HUM-GENE (301) 634-7300
Privacy Policy